title: Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin.
abstract: DNA nanoparticles (DNA NPs), which self-assemble from DNA plasmids and poly-L-lysine (pLL)-polyethylene glycol (PEG) block copolymers, transfect several cell types in vitro and in vivo with minimal toxicity and immune response. To further enhance the gene transfer efficiency of DNA NP and control its tropism, we established a strategy to efficiently attach peptide ligands to DNA NPs. The non-covalent biotin-streptavidin (SA) interaction was used for ligand conjugation to overcome problems associated with covalent conjugation methods. A fusion protein of SA with the HIV-1 TAT peptide was cloned, expressed, purified and attached to biotinylated DNA NPs. A modified SA system with tetrameric structure but monovalent biotin binding capacity was adopted and shown to reduce the aggregation of biotinylated DNA NPs compared to neutravidin. Compared to unmodified DNA NPs, TAT modified DNA NPs significantly enhanced in vitro gene transfer, particularly at low DNA concentrations. Studies of cellular uptake and cellular distribution of the DNA NPs indicated that attaching TAT enhanced binding of DNA NPs to cell surface but not internalization at high DNA concentrations. In vivo studies showed that TAT modified DNA NPs mediated equal level of gene transfer to the mouse airways via the luminal route compared to unmodified DNA NPs.
authors: Department of Biochemistry, Case Western Reserve University Schoolof Medicine, Cleveland, Ohio 44106, USA.
authors: Wenchao
authors: W
authors: Sun
authors: David
authors: D
authors: Fletcher
authors: Rolf Christiaan
authors: RC
authors: van Heeckeren
authors: Pamela B
authors: PB
authors: Davis
mesh_terms: D000818:Animals; D001710:Biotin / Q000378:metabolism*; D019921:Biotinylation / Q000379:methods; D002478:Cells, Cultured; D004247:DNA / Q000235:genetics / Q000378:metabolism*; D018014:Gene Transfer Techniques; D006367:HeLa Cells; D006801:Humans; D008024:Ligands; D008239:Lysine / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D053758:Nanoparticles / Q000737:chemistry*; D010455:Peptides / Q000235:genetics / Q000378:metabolism*; D011092:Polyethylene Glycols / Q000378:metabolism; D011108:Polymers / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism*; D019809:Streptavidin / Q000235:genetics / Q000378:metabolism*; D014162:Transfection / Q000379:methods; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000235:genetics / Q000378:metabolism*
chemical_list: D008024:Ligands; D010455:Peptides; D011108:Polymers; D011993:Recombinant Fusion Proteins; D054322:tat Gene Products, Human Immunodeficiency Virus; D011092:Polyethylene Glycols; D001710:Biotin; D004247:DNA; D019809:Streptavidin; D008239:Lysine